{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"INDUSTRY SESSION PODCAST: Rethinking the Economics of Bone Infection Care. Sponsored by BONESUPPORT\u2122","description":" This episode is sponsored by BONESUPPORT\u2122, maker of CERAMENT\u00ae G with Gentamicin \u2013 the one and only FDA authorized, antibiotic-eluting bone void filler. For more information, visit https:\/\/www.bonesupport.com\/en-us\/products\/cerament-g\/  Paul Matuszewski, MD, from University of Kentucky is joined by Chris Cosgrove, MD and Peter Everson, MD to discuss how they\u2019re using new technology and evidence to best care for their patients in today\u2019s cost-conscious landscape.  Over the course of forty minutes, they discuss their move towards single-stage surgeries, shortened antibiotic treatment regimens, and how they\u2019re even treating some of their patients outpatient with CERAMENT G. They also discuss the new CMS ruling for FY2027 and what it means for CERAMENT G.      Interested in staying in touch? Follow BONESUPPORT on LinkedIn https:\/\/www.linkedin.com\/company\/bonesupport-ab\/   References discussed in this episode:  \u00b7 Conway J, et al. \u2018Antibiotic Cement-Coated Rods.\u2019 Bone Joint J. vol. 96-B, no. 10, 2014, pp. 1349-1354. doi:10.1302\/0301-620X.96B10.33799.  \u00b7 McNally et al. \u2018Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate\/hydroxyapatite biocomposite: a prospective series of 100 cases.\u2019 Bone Joint J. 2016;98-B(9):1289-96  \u00b7 Godina M. Early microsurgical reconstruction of complex trauma of the extremities.\u202fPlast Reconstr Surg. 1986;78(3):285-292. doi:10.1097\/00006534-198609000-00001  \u00b7 McNally et al. \u2018Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier.\u2019 Bone Joint J. 2022;104-B(9):1095-1100.  \u00b7 Ferguson J et al., \u2018A Comparison of Clinical and Radiological Outcomes between Two Different Biodegradable Local Antibiotic Carriers Used in the Single- \u00adstage Surgical Management of Long Bone Osteomyelitis\u2019, Bone & Joint Research, 2023; 12(7): 412\u201322  \u00b7 Henry et al., \u2018Long-Term Follow-Up of Open Gustilo-Anderson IIIB Fractures Treated With an Adjuvant Local Antibiotic Hydroxyapatite Bio-Composite\u2019, Cureus. 2023; 15(5).   \u00b7 Li et al. \u2018Oral versus Intravenous Antibiotics for Bone and Joint Infection.\u2019 The New England Journal of Medicine, 2019; 380:425-436  \u00b7 Major Extremity Trauma Research Consortium (METRC). \u202f\u2018Oral vs intravenous antibiotics for fracture-related infections: the POvIV randomized clinical trial.\u2019\u202f\u202fJAMA Surg. 2025;160(3):276-284.  Information discussed regarding CMS:   \u00b7 Centers for Medicare & Medicaid Services (US). Medicare program; hospital inpatient prospective payment systems for acute care hospitals (IPPS) and the long-term care hospital prospective payment system and policy changes and fiscal year (FY) 2027 rates; requirements for quality programs; other policy changes; and adoption of updated versions of certain health information technology standards. Final rule (CMS-1849-F) [Internet]. Fed Regist. 2026 Aug 4 [cited 2026 Aug 20]. Available from: https:\/\/www.federalregister.gov\/documents\/2026\/08\/04\/2026-15833\/medicare-program-hospital-inpatient\u2026. Also available from: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2026-08-04\/pdf\/2026-15833.pdf ","author_name":"The OTA Podcast","author_url":"http:\/\/conveymd.libsyn.com\/website","html":"